Elevated levels of myeloperoxidase, white blood cell count and 3-chlorotyrosine in Taiwanese patients with acute myocardial infarction

2006 Libby, 2002, Inflammation and atherosclerosis, Circulation, 105, 1135, 10.1161/hc0902.104353 Festa, 2005, Inflammation and cardiovascular disease in patients with diabetes: lessons from the diabetes control and complications trial, Circulation, 111, 2414, 10.1161/01.CIR.0000167558.77793.E8 Zimmermann, 1999, Inflammation enhances cardiovascular risk and mortality in hemodialysis patients, Kidney Int, 55, 648, 10.1046/j.1523-1755.1999.00273.x Rutgers, 2003, The role of myeloperoxidase in the pathogenesis of systemic vasculitis, Clin Exp Rheumatol, 21, 55 Chisolm, 2000, The oxidative modification hypothesis of atherogenesis: an overview, Free Radic Biol Med, 28, 1815, 10.1016/S0891-5849(00)00344-0 Podrez, 2000, Myeloperoxidase-generated oxidants and atherosclerosis, Free Radic Biol Med, 28, 1717, 10.1016/S0891-5849(00)00229-X Naruko, 2002, Neutrophil infiltration of culprit lesions in acute coronary syndromes, Circulation, 106, 2894, 10.1161/01.CIR.0000042674.89762.20 Madjid, 2004, Leukocyte count and coronary heart disease: implications for risk assessment, J Am Coll Cardiol, 44, 1945, 10.1016/j.jacc.2004.07.056 Gaut, 2001, Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis, Proc Natl Acad Sci U S A, 98, 11961, 10.1073/pnas.211190298 Rosen, 2002, Human neutrophils use the myeloperoxidase–hydrogen peroxide–chloride system to chlorinate but not nitrate bacterial proteins during phagocytosis, J Biol Chem, 277, 30463, 10.1074/jbc.M202331200 Sugiyama, 2001, Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes, Am J Pathol, 158, 879, 10.1016/S0002-9440(10)64036-9 Lau, 2006, Myeloperoxidase and its contributory role in inflammatory vascular disease, Pharmacol Ther, 111, 16, 10.1016/j.pharmthera.2005.06.023 Nicholls, 2004, The role of myeloperoxidase in the pathogenesis of coronary artery disease, Jpn J Infect Dis, 57, S21 Zhang, 2002, Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation, J Biol Chem, 277, 46116, 10.1074/jbc.M209124200 Bergt, 2004, The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport, Proc Natl Acad Sci U S A, 101, 13032, 10.1073/pnas.0405292101 Eiserich, 2002, Myeloperoxidase, a leukocyte-derived vascular NO oxidase, Science, 296, 2391, 10.1126/science.1106830 Forgione, 2000, Roles of endothelial dysfunction in coronary artery disease, Curr Opin Cardiol, 15, 409, 10.1097/00001573-200011000-00007 Zidar, 2005, Neutrophils in human myocardia infarction with rupture of the free wall, Cardiovasc Pathol, 14, 247, 10.1016/j.carpath.2005.04.002 Fu, 2001, Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase, J Biol Chem, 276, 41279, 10.1074/jbc.M106958200 Sugiyama, 2004, Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis, Arterioscler Thromb Vasc Biol, 24, 1309, 10.1161/01.ATV.0000131784.50633.4f Hazen, 2004, Myeloperoxidase and plaque vulnerability, Arterioscler Thromb Vasc Biol, 24, 1143, 10.1161/01.ATV.0000135267.82813.52 Brennan, 2002, A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species, J Biol Chem, 277, 17415, 10.1074/jbc.M112400200 Kutter, 2000, Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit?, Acta Haematol, 104, 10, 10.1159/000041062 Nikpoor, 2001, A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians, Am Heart J, 142, 336, 10.1067/mhj.2001.116769 Domigan, 1995, Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils, J Biol Chem, 270, 16542, 10.1074/jbc.270.28.16542 Mohiuddin, 2006, Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system, J Surg Res, 133, 143, 10.1016/j.jss.2005.10.008 Denzler, 2001, Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation, J Immunol, 167, 1672, 10.4049/jimmunol.167.3.1672 Mita, 2004, Urinary 3-bromotyrosine and 3-chlorotyrosine concentrations in asthmatic patients: lack of increase in 3-bromotyrosine concentration in urine and plasma proteins in aspirin-induced asthma after intravenous aspirin challenge, Clin Exp Allergy, 34, 931, 10.1111/j.1365-2222.2004.01968.x Zhang, 2001, Endothelial dysfunction is induced by proinflammatory oxidant hypochlorous acid, Am J Physiol Heart Circ Physiol, 281, H1469, 10.1152/ajpheart.2001.281.4.H1469 Vita, 2004, Serum myeloperoxidase levels independently predict endothelial dysfunction in humans, Circulation, 110, 1134, 10.1161/01.CIR.0000140262.20831.8F Malle, 2006, Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins, Arch Biochem Biophys, 445, 245, 10.1016/j.abb.2005.08.008 Li, 2005, Changes of neutrophil myeloperoxidase in coronary circulation among patients with acute coronary syndrome, Zhonghua Xin Xue Guan Bing Za Zhi, 33, 1106 Chiu, 2005, Levels and value of soluble P-selectin following acute myocardial infarction: evaluating the link between soluble P-selectin levels and recruitment of circulating white blood cells and the marker for the rapid diagnosis of chest pain, Chang Gung Med J, 28, 699 Ross, 1999, Atherosclerosis—an inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207 Pearson, 2003, Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association, Circulation, 107, 499, 10.1161/01.CIR.0000052939.59093.45 Tsimikas, 2006, Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease, Am J Cardiol, 98, 9P, 10.1016/j.amjcard.2006.09.015 Askari, 2003, Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction, J Exp Med, 197, 615, 10.1084/jem.20021426 Horiuchi, 2003, Scavenger receptors for oxidized and glycated proteins, Amino Acids, 25, 283, 10.1007/s00726-003-0029-5 McCarthy, 2003, Association of genetic variants in the HDL receptor, SR-B1, with abnormal lipids in women with coronary artery disease, J Med Genet, 40, 453, 10.1136/jmg.40.6.453